Members of the Rogel Cancer Center present at ASTRO 2024
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™ 800-865-1125

Photo courtesy ASTRO
The American Society of Radiation Oncology 2024 annual meeting, will be Sept. 29-Oct. 2 at the Walter E. Washington Convention Center, Washington, D.C.
Rogel Cancer Center faculty and trainees will present or moderate more than three dozen sessions and posters. Check out the list of U-M presenters to support your colleagues. Connect with researchers on X (Twitter) using #ASTRO24. Be sure to tag @UMRogelCancer.
Presenter information is sometimes incomplete. If your session is missing, please email the abstract link to [email protected].
Sunday, Sept. 29
2:47-3:02 p.m. Room 202
Systemic Therapy in the Curative Management of Patients with HPV-Positive Oropharyngeal SCC (OPSCC)
Paul Swiecicki, M.D.
3:07-3:17 p.m. Room 140
3:45-3:45 p.m. Room 151
Relationship between Cannabis Use and Opioid Use in Patients with Cancer Metastatic to Bone in a Large Multicenter Cohort from a State with Legalized Adult Non-Medical Cannabis
Matthew Cousins, M.D., Ph.D.
4:55-5:05 p.m. Room 207B
155 - Novel Statistical-AI Method to Automate Discovery of Predictive Factors and Thresholds for 3 Year Survival, Dysphagia and Xerostomia for Patients with Head and Neck Cancers
Charles Mayo, Ph.D.
5:02-5:17 p.m. Room 151
Review of Use Case and Early Prospective Trials for Single Cancer Tests to Close Gaps and Reduce Inequities for Recommended Cancer Screening
Caitlin Schonewolf, M.D., M.S.
2:45-4:15 p.m. Hall C Poster: Lung Cancer/Thoracic Malignancies and Diversity, Equity and Inclusion in Healthcare
2037 - Prospective Evaluation of Non-Small Cell Lung Cancer Radiation Therapy Treatment Interruptions in a Large Statewide Quality Collaborative
Ameer Elaimy, M.D., Ph.D.
2065 - Characterizing Post-Treatment Cardiac and Pulmonary Hospitalizations in Locally Advanced Lung Cancer: A Statewide Quality Consortium Analysis
Shruti Jolly, M.D., M.B.A.
2101 - Parametric Response Mapping to Predict Pulmonary Toxicity from Thoracic Radiation
Sean Miller, M.D.
4:45-6 p.m. Hall C Posters: Physics
2381 - Application of Standardized Tissue Repair Discount Factors to Guide Spinal Cord Dose in Reirradiation
Josiah Nieto, M.D.
Monday, Sept. 30
8:14-8:26 a.m. Room 150
Radiobiology- and Radiophysics- Based Treatment Strategies to Preserve Sexual Function: Functional Anatomy Sparing Approaches, Altered Fractionation Schedules, and Moderating Androgen Deprivation Therapy
William McLaughlin, M.D.
10:45 a.m.- noon Room 158
ST 01 - Overlooked No More: Managing Provider Wellness after Medical Errors
Elizabeth Covington, Ph.D., moderator
11:05-11:20 a.m. Room 143
Best Practice for the Use of Interventional Radiological Techniques and Approaches in Liver-Directed Therapies for Limited Liver Metastases
Jared Christensen, M.D.
11:07-11:27 a.m. Room 151
HPV ctDNA Kinetics in the Definitive Setting
Michelle Mierzwa, M.D.
11:17-11:32 a.m. Room 209
Does the NCI Cancer Center Support Grant Structure Strengthen or Weaken Radiation Oncology Research and Innovation?
Theodore Lawrence, M.D., Ph.D.
11:35-11:47 a.m. Room 158
Challenges and Future Possibilities for Better Supporting Providers
Elizabeth Covington, Ph.D.
3-4 p.m. Hall C Posters: Breast Cancer and Nonmalignant Disease
2675 - Prospective Evaluation of Acute Toxicity from Tumor Bed Boost Following Whole Breast Radiotherapy
Michael Dykstra, M.D.
Tuesday, Oct. 01
8-8:10 a.m. Room 151
Science Highlight – Head & Neck Cancer
Michelle Mierzwa, M.D., discussant
8:32-8:47 a.m. Room 207
Clinical Implementation of the Special Medical Physics Consult for Reirradiation
Kelly Paradis, Ph.D.
8:50-9 a.m. Room 140
1041 - Progress in Shortening Treatment Courses for Bone Metastases in a Statewide Quality Consortium
Luke Higgins, M.D.
8-9 a.m. Room 152
Phys 9: Imaging for Planning
Daniel Polan, PH.D., moderator
12:45-2 p.m. Room 152
Phys 5: Response Assessment
Yue Cao, Ph.D., moderator
2:32-2:44 p.m. Room 143
Histotripsy - A New Era in Cancer Therapy
Michael Green, M.D., Ph.D.
4:10-4:20 p.m. Room 152
5:45-5:55 p.m. Room 146
331 - Imaging Metrics and HPV ctDNA Kinetics in a Phase II Immuno-Chemoradiation Trial for Locoregionally Advanced p16+ Oropharynx Cancer
Samuel Regan, M.D.
2:30-3:45 p.m. Hall C Posters: Genitourinary Cancer, Patient Safety, and Nursing/Supportive Care
3165 - Evaluating Guideline-Concordant Androgen Deprivation for High-Risk Prostate Cancer in a Statewide Quality Consortium
Michael Dykstra, M.D.
3195 - Androgen Suppression with abiraterone aCetate, LEuprolide, PARP Inhibition and Stereotactic Body Radiotherapy (ASCLEPIuS) in High-Risk and Node Positive Prostate Cancer (PCa): Phase I Multicenter Results
William Jackson, M.D.
3240 - Uptake and Positivity Rates of PSMA PET Staging for Newly Diagnosed Prostate Cancer in a National Healthcare System
Sean Miller, M.D.
3264 - Ultra-Short-Course Hormone Therapy for Intermediate Risk Prostate Cancer Treated with Definitive Radiotherapy: Retrospective Analysis of a National Healthcare System
Travis Pflederer, M.D.
3264 - Ultra-Short-Course Hormone Therapy for Intermediate Risk Prostate Cancer Treated with Definitive Radiotherapy: Retrospective Analysis of a National Healthcare System
Alex Bryant, M.D., M.S.
3270 - Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative
Samuel Regan, M.D.
3295 - Implications of Rectal Wall Gel Placement in Treatment Delay
Grace Sun, M.D.
4-5 p.m. Hall C Posters: Hematologic Malignancies and Digital Health Innovations
3440 - Current Use and Perspectives of Artificial Intelligence in Radiation Oncology: A Statewide Consortium Survey
Amina Tanweer, B.S.
Wednesday, Oct. 02
8-8:10 a.m. Room 151
Science Highlights – Gastrointestinal Cancer
Daniel Chang, M.D., discussant
10:30-11:45 a.m. Room 145
Phys 7: Best of Physics
James Balter, Ph.D., moderator
12:30-1:30 p.m. Room 144
Phys 13: Clinical Data and Dose Evaluation
Martha Matuszak, Ph.D., moderator
1-1:10 p.m. Room 144
1146 - Deep Learning-Based Dose Prediction for Thoracic Radiation in a Statewide Radiation Oncology Quality Consortium
Daniel Polan, Ph.D.
10:30-11:45 a.m. Hall C Posters: Head & Neck Cancer and Health Services Research/Global Oncology
3640 - Treatment Planning Workflow and Perceptions about Automated Contouring and Treatment Planning in Africa
Michael Dykstra, M.D.
3641 - CT Simulator Downtime in Africa: Survey Results from AORTIC 2023
Michael Dykstra, M.D..
3706 - Time and Financial Toxicity Implications during Consideration of Pembrolizumab Infusion Frequency
Santosh Nori, B.S., M.P.H.